nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—BCHE—peripheral nervous system neoplasm	0.61	1	CbGaD
Rivastigmine—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0608	0.433	CbGbCtD
Rivastigmine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0232	0.165	CbGbCtD
Rivastigmine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0216	0.154	CbGbCtD
Rivastigmine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00991	0.0705	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00974	0.0693	CbGbCtD
Rivastigmine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00908	0.0646	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00619	0.0441	CbGbCtD
Rivastigmine—Pyridostigmine—BCHE—peripheral nervous system neoplasm	0.0028	0.487	CrCbGaD
Rivastigmine—Neostigmine—BCHE—peripheral nervous system neoplasm	0.00212	0.369	CrCbGaD
Rivastigmine—Neostigmine—ABCB1—peripheral nervous system neoplasm	0.000831	0.144	CrCbGaD
Rivastigmine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.00022	CcSEcCtD
Rivastigmine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.36e-05	0.00022	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000218	CcSEcCtD
Rivastigmine—Rash—Dactinomycin—peripheral nervous system neoplasm	5.33e-05	0.000218	CcSEcCtD
Rivastigmine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.32e-05	0.000218	CcSEcCtD
Rivastigmine—Renal failure—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000216	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.28e-05	0.000216	CcSEcCtD
Rivastigmine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.28e-05	0.000216	CcSEcCtD
Rivastigmine—Fatigue—Etoposide—peripheral nervous system neoplasm	5.27e-05	0.000216	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	5.27e-05	0.000216	CcSEcCtD
Rivastigmine—Constipation—Etoposide—peripheral nervous system neoplasm	5.23e-05	0.000214	CcSEcCtD
Rivastigmine—Pain—Etoposide—peripheral nervous system neoplasm	5.23e-05	0.000214	CcSEcCtD
Rivastigmine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000214	CcSEcCtD
Rivastigmine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000214	CcSEcCtD
Rivastigmine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000214	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000212	CcSEcCtD
Rivastigmine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.18e-05	0.000212	CcSEcCtD
Rivastigmine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.17e-05	0.000212	CcSEcCtD
Rivastigmine—Sweating—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000211	CcSEcCtD
Rivastigmine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.000211	CcSEcCtD
Rivastigmine—Haematuria—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.00021	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000208	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000208	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000208	CcSEcCtD
Rivastigmine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000208	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000207	CcSEcCtD
Rivastigmine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000206	CcSEcCtD
Rivastigmine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.04e-05	0.000206	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000206	CcSEcCtD
Rivastigmine—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.02e-05	0.000206	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000205	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5e-05	0.000205	CcSEcCtD
Rivastigmine—Dizziness—Vincristine—peripheral nervous system neoplasm	4.99e-05	0.000204	CcSEcCtD
Rivastigmine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.98e-05	0.000204	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000204	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000204	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000204	CcSEcCtD
Rivastigmine—Rash—Alitretinoin—peripheral nervous system neoplasm	4.94e-05	0.000202	CcSEcCtD
Rivastigmine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.94e-05	0.000202	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000202	CcSEcCtD
Rivastigmine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.92e-05	0.000201	CcSEcCtD
Rivastigmine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000201	CcSEcCtD
Rivastigmine—Headache—Alitretinoin—peripheral nervous system neoplasm	4.91e-05	0.000201	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.0002	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.0002	CcSEcCtD
Rivastigmine—Urticaria—Etoposide—peripheral nervous system neoplasm	4.86e-05	0.000199	CcSEcCtD
Rivastigmine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000199	CcSEcCtD
Rivastigmine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000198	CcSEcCtD
Rivastigmine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.84e-05	0.000198	CcSEcCtD
Rivastigmine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.84e-05	0.000198	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000198	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000198	CcSEcCtD
Rivastigmine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000198	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000198	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000197	CcSEcCtD
Rivastigmine—Vomiting—Vincristine—peripheral nervous system neoplasm	4.8e-05	0.000197	CcSEcCtD
Rivastigmine—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.79e-05	0.000196	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000196	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000195	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000195	CcSEcCtD
Rivastigmine—Rash—Vincristine—peripheral nervous system neoplasm	4.76e-05	0.000195	CcSEcCtD
Rivastigmine—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.76e-05	0.000195	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000195	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000194	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000194	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000194	CcSEcCtD
Rivastigmine—Headache—Vincristine—peripheral nervous system neoplasm	4.73e-05	0.000194	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000193	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000192	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000191	CcSEcCtD
Rivastigmine—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.65e-05	0.000191	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.00019	CcSEcCtD
Rivastigmine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.57e-05	0.000187	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000187	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000186	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000185	CcSEcCtD
Rivastigmine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.51e-05	0.000185	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000184	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000184	CcSEcCtD
Rivastigmine—Nausea—Vincristine—peripheral nervous system neoplasm	4.48e-05	0.000184	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000183	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000183	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000183	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000183	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000183	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000182	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000181	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000181	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.00018	CcSEcCtD
Rivastigmine—Asthenia—Etoposide—peripheral nervous system neoplasm	4.39e-05	0.00018	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.00018	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.000179	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000179	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000178	CcSEcCtD
Rivastigmine—Chills—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000177	CcSEcCtD
Rivastigmine—Pruritus—Etoposide—peripheral nervous system neoplasm	4.33e-05	0.000177	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000177	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000176	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.26e-05	0.000175	CcSEcCtD
Rivastigmine—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.24e-05	0.000174	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.000173	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000173	CcSEcCtD
Rivastigmine—Rash—Cisplatin—peripheral nervous system neoplasm	4.21e-05	0.000172	CcSEcCtD
Rivastigmine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.21e-05	0.000172	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000172	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000172	CcSEcCtD
Rivastigmine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.18e-05	0.000171	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000171	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.00017	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.00017	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.00017	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000169	CcSEcCtD
Rivastigmine—Tension—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000169	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000168	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000167	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000166	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000166	CcSEcCtD
Rivastigmine—Dizziness—Etoposide—peripheral nervous system neoplasm	4.04e-05	0.000166	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000165	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000165	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000164	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000163	CcSEcCtD
Rivastigmine—Nausea—Cisplatin—peripheral nervous system neoplasm	3.97e-05	0.000162	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000162	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.95e-05	0.000162	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.00016	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.00016	CcSEcCtD
Rivastigmine—Vomiting—Etoposide—peripheral nervous system neoplasm	3.89e-05	0.000159	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000159	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000159	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000159	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000158	CcSEcCtD
Rivastigmine—Rash—Etoposide—peripheral nervous system neoplasm	3.86e-05	0.000158	CcSEcCtD
Rivastigmine—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.85e-05	0.000158	CcSEcCtD
Rivastigmine—Headache—Etoposide—peripheral nervous system neoplasm	3.83e-05	0.000157	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000157	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000156	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000156	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000155	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000155	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000155	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000154	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000154	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000153	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000152	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000151	CcSEcCtD
Rivastigmine—Cough—Epirubicin—peripheral nervous system neoplasm	3.67e-05	0.00015	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.00015	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.64e-05	0.000149	CcSEcCtD
Rivastigmine—Nausea—Etoposide—peripheral nervous system neoplasm	3.63e-05	0.000149	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000148	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000148	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000147	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000146	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000146	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000146	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000146	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000146	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000145	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000145	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000144	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000143	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000143	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000143	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000142	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000141	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.00014	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.00014	CcSEcCtD
Rivastigmine—Infection—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000139	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000139	CcSEcCtD
Rivastigmine—Shock—Epirubicin—peripheral nervous system neoplasm	3.37e-05	0.000138	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.000138	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000138	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000137	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000137	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000137	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000136	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000136	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000135	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000135	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000135	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000135	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000135	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.000134	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000134	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000133	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000131	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000131	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.00013	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000129	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000128	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—peripheral nervous system neoplasm	3.12e-05	0.000128	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000127	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000127	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.1e-05	0.000127	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000127	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000126	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000126	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000126	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000125	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000125	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000124	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000124	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000122	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000121	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000121	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000121	CcSEcCtD
Rivastigmine—Pain—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.00012	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.00012	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000118	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.87e-05	0.000117	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000117	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000116	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.83e-05	0.000116	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	0.000115	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000115	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000114	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000113	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000112	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000112	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.72e-05	0.000112	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000111	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000111	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000111	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000111	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000107	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000106	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.000103	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.000103	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000103	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000103	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.46e-05	0.000101	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.43e-05	9.93e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.35e-05	9.6e-05	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	9.57e-05	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.28e-05	9.32e-05	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.27e-05	9.28e-05	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	9.19e-05	CcSEcCtD
Rivastigmine—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.18e-05	8.93e-05	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	8.89e-05	CcSEcCtD
Rivastigmine—Rash—Epirubicin—peripheral nervous system neoplasm	2.16e-05	8.85e-05	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.16e-05	8.84e-05	CcSEcCtD
Rivastigmine—Headache—Epirubicin—peripheral nervous system neoplasm	2.15e-05	8.79e-05	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.1e-05	8.59e-05	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—peripheral nervous system neoplasm	2.04e-05	8.34e-05	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	8.26e-05	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—peripheral nervous system neoplasm	2e-05	8.19e-05	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2e-05	8.18e-05	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—peripheral nervous system neoplasm	1.99e-05	8.14e-05	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	7.71e-05	CcSEcCtD
